Knockdown of IGF2BP2 overcomes cisplatin-resistance in lung cancer through downregulating Spon2 gene
Knockdown of IGF2BP2 overcomes cisplatin-resistance in lung cancer through downregulating Spon2 gene
About this item
Full title
Author / Creator
Zhang, Shilei , Dou, Ting , Li, Hong , Yu, Hongfang , Zhang, Wei , Sun, Liping , Yang, Jingwen , Wang, Zhenfei and Yang, Hao
Publisher
England: Springer
Journal title
Language
English
Formats
Publication information
Publisher
England: Springer
Subjects
More information
Scope and Contents
Contents
Cisplatin (DDP) resistance has long posed a challenge in the clinical treatment of lung cancer (LC). Insulin-like growth factor 2 binding protein 2 (IGF2BP2) has been identified as an oncogenic factor in LC, whereas its specific role in DDP resistance in LC remains unclear.
In this study, we investigated the role of IGF2BP2 on DDP resistance in...
Alternative Titles
Full title
Knockdown of IGF2BP2 overcomes cisplatin-resistance in lung cancer through downregulating Spon2 gene
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_02680d40650e4deebd7349ac9aae0673
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_02680d40650e4deebd7349ac9aae0673
Other Identifiers
ISSN
1601-5223,0018-0661
E-ISSN
1601-5223
DOI
10.1186/s41065-024-00360-w
